Clin Chem 1966, 12:58–69 PubMed 25 Carter P: Spectrophotometric

Clin Chem 1966, 12:58–69.PubMed 25. Carter P: Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal Biochem 1971, 40:450–458.PubMedCrossRef

26. Benzie IFF, Strainb JJ: The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay. Anal Biochem 1996, 239:70–76.PubMedCrossRef 27. Brewer KJ, Murphy JWR, Petersen JD: Synthesis and characterization of monometallic and bimetallic mixed-ligand complexes of iron(II) containing 2,2′-bipyrimidine or 2,3-bis(2-pyridyl) BAY 11-7082 in vitro pyrazine. Inorg Chem 1987, 26:3376–3379.CrossRef 28. Van Kampen EJ, learn more Zijlstra WG: Determination of hemoglobin and its derivatives. Adv Clin Chem 1965, 8:141–187.PubMedCrossRef 29. Van Kampen EJ, Zijlstra WG: Spectrophotometry of hemoglobin and hemoglobin derivatives. Adv Clin Chem 1983, 23:199–257.PubMedCrossRef 30. Trivedi RC, Rebar L, Berta E, Stong L: New enzymatic method for serum uric acid at 500 nm. Clin Chem 1978, 24:1908–1111.PubMed 31. Khoschsorur GA, Winklhofer-Roob BM, Rabl H, Auer T, Peng Z, Schaur RJ: Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application

of the method to different biological materials. Ulixertinib Chromatographia 2000, 52:181–184.CrossRef 32. Kingsley M, Cunningham D, Mason L, Kilduff LP, McEneny J: Role of creatine supplementation on exercise-induced cardiovascular function and oxidative stress. Oxid Med Cell Longev 2009, 2:247–254.PubMedCrossRef 33. Sestili P, Barbieri E, Martinelli C, Battistelli M, Guescini M, Vallorani L, Casadei L, D’Emilio A, Falcieri E, Piccoli G, Agostini D, Annibalini

G, Paolillo M, Gioacchini AM, Stocchi V: Creatine supplementation prevents the inhibition of myogenic differentiation in oxidatively injured C2C12 murine myoblasts. Mol Nutr Food Res 2009, 53:1187–1204.PubMedCrossRef 34. Harris RC, Söderlund K, Hultman E: Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci 1992, 83:367–374.PubMed 35. Reif DW: Ferritin as a source of iron for oxidative Protein Tyrosine Kinase inhibitor damage. Free Radic Biol Med 1992, 12:417–427.PubMedCrossRef 36. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P: Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J 1986, 235:747–754.PubMed 37. Mazur A, Carleton A, Carlsen A: Relation of oxidative metabolism to the incorporation of plasma iron into ferritin in vivo. J Biol Chem 1961, 236:1109–1116.PubMed 38. Mazur A, Baez S, Shorr E: The mechanism of iron release from ferritin as related to its biological properties. J Biol Chem 1955, 213:147–160.PubMed 39. Hellsten Y, Frandsen U, Orthenblad N, Sjodin B, Richter EA: Xanthine oxidase in human skeletal muscle following eccentric exercise: a role in inflammation. J Physiol 1997, 498:239–248.PubMed 40.

Comments are closed.